A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2001
12/13/2001	WO2001027136A3 Peptides which stimulate the immune response and tissue regeneration
12/13/2001	WO2001026682A3 Modified plant viruses and methods of use thereof
12/13/2001	WO2000006194A9 Depletion of cells responsible for antibody-mediated graft rejection
12/13/2001	US20010051650 Topical compositions comprising ascomycins
12/13/2001	US20010051646 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/13/2001	US20010051609 Administering Dna
12/13/2001	US20010051155 Using immunoglobulin binding epitopes
12/13/2001	DE10101324C1 New 1-(dimercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, are stable matrix metalloproteinase inhibitors useful e.g. for treating rheumatism, tumor metastasis or sunburn
12/13/2001	CA2707766A1 Plasmids ptqomp and ptto-1 which have an ompa signal sequence
12/13/2001	CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation
12/13/2001	CA2412026A1 Immunostimulatory rna/dna hybrid molecules
12/13/2001	CA2411762A1 Method for obtaining characterised muscle-derived cell populations and uses
12/13/2001	CA2411596A1 Therapeutic agents - ii
12/13/2001	CA2411578A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form
12/13/2001	CA2411575A1 Immunostimulatory oligodeoxynucleotides
12/13/2001	CA2411542A1 Encapsulation of polynucleotides and drugs into targeted liposomes
12/13/2001	CA2411470A1 T cell receptor fusions and conjugates and methods of use thereof
12/13/2001	CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001	CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives
12/13/2001	CA2411010A1 Tetracyclic diketopiperazine compounds as pdev inhibitors
12/13/2001	CA2410509A1 Indolinone derivatives as protein kinase/phosphatase inhibitors
12/13/2001	CA2410188A1 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
12/13/2001	CA2409392A1 Intracellular signaling proteins
12/13/2001	CA2409015A1 Caspase inhibitors and uses thereof
12/13/2001	CA2408748A1 Nuclear hormone receptor
12/13/2001	CA2408688A1 Method to induce the th1 immune response
12/12/2001	EP1161955A2 Induction of immunological tolerance for graft transplantation by the use of humanized non-depleting anti-cd4 antibodies in combination with specific donor bone marrow cells
12/12/2001	EP1161954A1 Treatment of T cell mediated autoimmune disorders
12/12/2001	EP1161952A2 Human therapeutic uses of BPI protein products
12/12/2001	EP1161562A1 Deleted sequences in m. bovis bcg/m. bovis or m. tuberculosis, method for detecting mycobacteria using said sequences and vaccines
12/12/2001	EP1161550A1 Target cell-specific, multivalent proteins (mvp)
12/12/2001	EP1161549A2 Retrovirus producing cells utilizing a high multiplicity of transduction
12/12/2001	EP1161456A2 Antibody and chemokine constructs and their use for treating autoimmune diseases
12/12/2001	EP1161446A1 50 human secreted proteins
12/12/2001	EP1161444A1 A novel inhibitor of programmed cell death
12/12/2001	EP1161442A2 Exocytosis pathway proteins and methods of use
12/12/2001	EP1161440A1 Method for refolding molecules of polypeptides containing ig domains
12/12/2001	EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
12/12/2001	EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors
12/12/2001	EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001	EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161410A1 Retinoid antagonists and use thereof
12/12/2001	EP1161261A1 Apoptosis inducing molecule ii and methods of use
12/12/2001	EP1161257A2 Pharmaceutical compositions comprising tgf-beta
12/12/2001	EP1161254A1 Treatment of autoimmune diseases with american ginseng extract
12/12/2001	EP1161250A1 Immunostimulant bacterial membrane fractions in cancer treatment
12/12/2001	EP1161235A1 Combinations for the treatment of diseases involving angiogenesis
12/12/2001	EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001	EP1161147A1 Peptide mimics useful for treating disease
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0785802B1 Saponin preparations and use thereof in iscoms
12/12/2001	EP0782456B1 Conjugate consisting of an active substance and a non-exogenous native protein
12/12/2001	EP0748319B1 Process for making an epoxide
12/12/2001	EP0666758B1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/12/2001	EP0655921B1 Novel glucan preparation
12/12/2001	EP0522091B1 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis
12/12/2001	CN1326505A Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
12/12/2001	CN1326466A Method of producing functional immunoglubulin superfaminly protein
12/12/2001	CN1326458A CRF receptor antagonists and methods relating thereto
12/12/2001	CN1326457A 4-aminopyrrolopyrimidines as kinase inhibitors
12/12/2001	CN1326443A Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
12/12/2001	CN1326440A Piperdine CCR-3 receptor antagonists
12/12/2001	CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells
12/12/2001	CN1326358A Method of DNA vaccination
12/12/2001	CN1326355A Method of treating heparin-induced thrombocytopenia
12/12/2001	CN1326351A Use of certain drugs for treating nerve root injury
12/12/2001	CN1326344A PUFA supplements
12/12/2001	CN1325717A Health-care food prepared from extracts of animals bone marrow and Chinese-medicinal materials
12/12/2001	CN1325686A Flavonoids used as anti-rejection agent
12/11/2001	US6329511 Humanized mouse af2 immunoglobulin having specific amino acid sequences; treatment of autoimmune diseases
12/11/2001	US6329507 Dimer and multimer forms of single chain polypeptides
12/11/2001	US6329499 Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
12/11/2001	US6329415 Aromatic heterocyclic compounds as antiinflammatory agents
12/11/2001	US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001	US6329397 Hydroxy pipecolate hydroxamic acid derivatives
12/11/2001	US6329392 Substituted piperidines useful for the treatment of allergic diseases
12/11/2001	US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders
12/11/2001	US6329380 Pyrimidine benzimidizazole, pyrimidineimidazole or pyridine imidazole compounds for anticancer agents or atherosclerosis
12/11/2001	US6329372 Phenylalanine derivatives
12/11/2001	US6329370 Cardiovascular disorders and tumor necrosis factor (hereinafter tnf.sub..alpha.), a cytokine with pro-inflammatory activity
12/11/2001	US6329365 Inhibitors of interleukin-1β converting enzyme
12/11/2001	US6329362 Modulation cell adhesion the compounds are able to inhibit the binding of alpha 4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.
12/11/2001	US6329344 Urea derivative of alkylene dioxyfuran ethers
12/11/2001	US6329340 Human Defensin DEF-X
12/11/2001	US6329202 Antibodies directed against binding associated epitopes
12/11/2001	US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues
12/11/2001	US6328975 Recombinant swinepox virus
12/11/2001	US6328972 Compositions and methods for inducing cytotoxic T lymphocyte responses by immunization with protein antigens
12/11/2001	US6328970 Rapamycin position 27 conjugates
12/11/2001	US6328969 Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen
12/11/2001	US6328967 Delivery system to modulate immune response
12/11/2001	US6328965 Vaccine adjuvants
12/11/2001	US6328964 Method to treat multiple sclerosis with GP39-specific antibodies
12/11/2001	US6328960 Administering to transplant recipient mesenchymal stem cells in an amount effective to reduce an immune response of effector cells against an alloantigen to effector cells
12/11/2001	US6328954 Use of the IL-4 receptor for the therapy prophylaxis and diagnosis of allergic viral parasitic and bacterial diseases and of fungal infections
12/11/2001	CA2329482C Recombinant antibodies specific for tnf-.alpha.
12/11/2001	CA2218643C Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
12/11/2001	CA2213108C 2-aminobenzazapine derivatives
12/11/2001	CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same

1 ... 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 ... 1172